MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$753,102K
Marketable securities
$219,054K
Prepaid expenses and
other current assets
$48,871K
Property and equipmentat
cost
$32,850K
Total current assets
$1,021,027K
Property and equipment,
net
$23,682K
Right-of-use assets
$19,652K
Restricted cash and other
assets
$15,589K
Less accumulated
depreciation and...
$9,168K
Total assets
$1,079,950K
Total liabilities and
stockholders equity
$1,079,950K
Total stockholders
equity
$865,055K
Total liabilities
$214,895K
Accumulated deficit
-$1,516,996K
Accumulated other
comprehensive loss (gain)
-$137K
Additional paid-in capital
$2,382,172K
Long-term debt, net
$149,375K
Total current
liabilities
$51,249K
Lease liabilities,
net of current...
$14,271K
Common stock, 0.0001
par value...
$16K
Unamortized debt discount
and issuance costs
$1,546K
Principal term loan
balance
$150,000K
Accrued expenses and
other current...
$29,211K
Accounts payable
$10,781K
Vendor financing
arrangement
$6,224K
Lease liabilities
$5,033K
Accrued end of term fee
$921K
Back
Back
Balance Sheet
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)
source: myfinsight.com